Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIO) EBT (2021 - 2025)

Cardio Diagnostics Holdings' EBT history spans 5 years, with the latest figure at -$1.7 million for Q3 2025.

  • For Q3 2025, EBT fell 21.38% year-over-year to -$1.7 million; the TTM value through Sep 2025 reached -$6.6 million, up 20.61%, while the annual FY2024 figure was -$8.4 million, 0.08% changed from the prior year.
  • EBT for Q3 2025 was -$1.7 million at Cardio Diagnostics Holdings, down from -$1.7 million in the prior quarter.
  • Across five years, EBT topped out at $202269.0 in Q3 2022 and bottomed at -$4.2 million in Q1 2024.
  • The 5-year median for EBT is -$1.4 million (2023), against an average of -$1.4 million.
  • The largest YoY upside for EBT was 28153.95% in 2022 against a maximum downside of 211990.18% in 2022.
  • A 5-year view of EBT shows it stood at -$144837.0 in 2021, then tumbled by 1541.89% to -$2.4 million in 2022, then skyrocketed by 41.59% to -$1.4 million in 2023, then decreased by 9.39% to -$1.5 million in 2024, then decreased by 12.85% to -$1.7 million in 2025.
  • Per Business Quant, the three most recent readings for CDIO's EBT are -$1.7 million (Q3 2025), -$1.7 million (Q2 2025), and -$1.6 million (Q1 2025).